The volume of clinical research continues to grow, yet the standards to establish and validate claims, especially as related to clinical practice, have not followed suit. NEJM Evidence expands the corpus of published research with a focus on providing more context and critical evaluation of the methods and results to support clinical decision-making, but does so in a way that respects the time and commitment of the practitioner.
Frequency: Monthly (12 issues/year) with continuous publication
The process of generating evidence is a key area of focus for NEJM Evidence. We push readers to evaluate the reasoning behind the complex decisions that investigators make in trial design and execution and to assess the quality of evidence produced in trials. Our goal is to build a community that takes a sophisticated approach to evaluating evidence and assessing its impact on clinical decisions.
NEJM Evidence also guides readers toward a deeper understanding of the statistical methods used in trials. We provide concise, digestible explanations of these methods and how to interpret the resulting data. In addition, we introduce readers to emerging statistical methods and types of data that will play an increasingly prominent role in future trials.
The journal publishes content relevant across all general medical disciplines with an emphasis on cardiology, oncology, and infectious diseases. Physician-scientists, general medicine clinicians, subspecialty physicians, and clinical trialists will all benefit from this publication.
NEJM Evidence physician-editors are dedicated to advancing clinical medicine and working with clinicians on improving clinical trial studies.
Jeffrey M. Drazen, MD
Jeff joined the New England Journal of Medicine (NEJM) as Editor-in-Chief in 2000 and was appointed Editor-in-Chief, NEJM Group, in 2012, serving in both roles until 2019. He is now NEJM Group Editor and Editor-in-Chief of NEJM Evidence.
Chana A. Sacks, MD, MPH
Chana joined NEJM as a 2014-2015 NEJM Editorial Fellow and has served as Editor of Images in Clinical Medicine since 2016. She is Co-Director of the Massachusetts General Hospital (MGH) Center for Gun Violence Prevention and a Clinician-Investigator in the MGH’s Division of General Internal Medicine and Mongan Institute, where she is also a Health Policy Researcher.
C. Corey Hardin, MD, PhD
Corey joined NEJM as Reviews Editor in 2021. He is an Assistant Professor of Medicine at Harvard Medical School and a member of the joint Harvard-MIT Program in Health Sciences and Technology faculty.
Sharon-Lise T. Normand, MSc, PhD
Sharon-Lise joined NEJM as a Statistical Editor in 2017. She is the S. James Adelstein Professor of Health Care Policy in the Department of Health Care Policy at Harvard Medical School and a Professor in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health.
Siri Kadire, MD
Siri is an Editorial Fellow with NEJM. She holds a BA in medicine, health, and society from Vanderbilt University and an MD from the University of Tennessee. She completed her training in internal medicine at Indiana University and plans to pursue a fellowship in cardiovascular disease.
Neil joined NEJM in 2012, working in both manuscript editing and editorial operations. In 2016, he became the Executive Assistant to Jeff Drazen. He holds a BA in strategic communications from The Ohio State University.
860 Winter Street
Waltham, MA 02451-1413
Please address general editorial inquiries and correspondence to the editorial office:
Online access is available for purchase at an institution-wide level. For more information, contact the NEJM Group institution sales team at email@example.com.